Daesang Corporation revealed it backed out from its plan to buy the China-based food company, Heilongjiang Chengfu Food Group Co. It aimed to acquire a 51% stake in the company, which has now been withdrawn.
According to The Korea Economic Daily, the original plan was to purchase over half of the company's stake, trimmed to 20%. The South Korean food giant reportedly changed its decision as the amino acid product market slowed.
Purpose of the Initial Bid
Daesang Corp. was trying to acquire a controlling stake in Heilongjiang Chengfu Food to increase its presence in the Chinese market. The latter is a leading food additives manufacturer in China, and its position would also benefit Daesang.
Daesang and Heilongjiang Chengfu Food already agreed to an up to 51% acquisition deal in 2021, worth KRW26.5 billion. However, the former announced on Thursday this week that it will just buy 20% of Chengfu Food for KRW8.84 billion. The company said the acquisition may be completed by Sept. 7
"We had to make changes to our deal given the sluggishness of the lysine business in China. Through our minority stake investment, however, we will continue cooperating with Chengfu Food in functional amino acid products such as L-arginine for feed and L-tryptophan," a Daesang official said.
Sluggish Market Pushed Daesang to Retract Bid
Finally, Daesang Group stressed that the slow market for lysine has prompted it to retract its bid. As per the Financial Supervisory Service's Electronic Disclosure System, the company revised its plan for the deal and has now reduced the stake it would buy. New Daily reported that the expected share will also be reduced from 32.87% to 20%.
Photo by: Daesang Website


Elon Musk's Terafab Foundry Courts Top Chipmaking Giants for AI Self-Sufficiency Push
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants
Anthropic Nears $800 Billion Valuation as Investor Confidence Surges
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear
Federal Agencies Secretly Test Anthropic's AI Despite Trump Administration Ban
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push
Amazon in Advanced Talks to Acquire Globalstar in Starlink Rivalry Move
Hermès Q1 2026 Sales Miss Expectations Amid Iran War and China Slowdown
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle
Elliott Investment Takes ~3% Stake in Daikin, Pushes for Buybacks and Strategic Overhaul
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 



